Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001178913-21-001175
Filing Date
2021-03-25
Accepted
2021-03-25 09:30:41
Documents
5
Effectiveness Date
2021-03-25

Document Format Files

Seq Description Document Type Size
1 S-8 zk2125809.htm S-8 87810
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 5569
3 EXHIBIT 23.2 exhibit_23-2.htm EX-23.2 4022
4 capture.jpg GRAPHIC 10435
5 image00002.jpg GRAPHIC 63765
  Complete submission text file 0001178913-21-001175.txt   195288
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: S-8 | Act: 33 | File No.: 333-254692 | Film No.: 21770367
SIC: 2834 Pharmaceutical Preparations